Autolus Therapeutics to host Investor Conference Calls
Autolus Therapeutics to host Investor Conference Calls through June LONDON May 26 2020 -- Autolus Therapeutics plc (Nasdaq AUTL) a clinical-stage biopharmaceutical company developing
Get PriceAutolus Therapeutics reschedules its investor EHA
Jun 08 2020 · Autolus Therapeutics reschedules its investor EHA conference call Conference call and webcast to be held Friday June 12 2020 at 07 30 am
Get PriceSyncona Ltd. (via Public) / Autolus Therapeutics to host
Autolus Therapeutics plc (Nasdaq AUTL) a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies today announced that management will host an investor conference call to discuss AUTO3 data presented at the European Society for Medical Oncology (ESMO) Virtual Congress 2020 and to participate in Banking conferences through September
Get PriceAutolus Therapeutics to host Investor Conference Call to
Nov 17 2020 · Autolus Therapeutics plc (Nasdaq AUTL) a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies today announced that management will host an investor conference call to discuss AUTO1 and AUTO3 data presented at the American Society of Hematology (ASH) Virtual Congress 2020 and will also participate in
Get PriceAutolus Therapeutics Limited (spons. ADRs) hosts
Mar 03 2021 · The company Autolus Therapeutics Limited (spons. ADRs) is set to host investors and clients on a conference call on 3/4/2021 10 26 30 PM. The call comes after the company s earnings which are
Get PriceAutolus Therapeutics to host Investor Conference Call to
Nov 17 2020 · 7 December 2020Dr. Christian Itin chairman and chief executive officer along with the Autolus clinical team will host an investor call and webcast at 4.00 pm ET 9.00 pm GMT to discuss
Get PriceAutolus Therapeutics to host Investor Conference Call to
Nov 17 2020 · LONDON Nov. 17 2020 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq AUTL) a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies today announced that management will host an investor conference call to discuss AUTO1 and AUTO3 data presented at the American Society of Hematology (ASH) Virtual Congress 2020 and
Get PriceAutolus Therapeutics to host Investor Conference Call to
Nov 17 2020 · Autolus Therapeutics to host Investor Conference Call to discuss AUTO1 and AUTO3 data presented at ASH and to participate in the Jefferies Virtual London Healthcare Conference November 17 2020 at 7 00 AM EST
Get PriceAutolus Therapeutics reschedules its investor EHA
Autolus Therapeutics plc (Nasdaq AUTL) a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies today announced that it has rescheduled its investor conference call to discuss data at the European Hematology Association EHA25 Virtual Congress to 12 June 2020 at 7.30 am EDT 12.30 pm BST.
Get PriceAutolus Therapeutics to host Investor Conference Call to
LONDON Sept. 08 2020 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq AUTL) a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies today announced that management will host an investor conference call to discuss AUTO3 data presented at the European Society for Medical Oncology (ESMO) Virtual Congress 2020 and to
Get PriceAutolus Therapeutics to host Investor Conference Call to
Nov 17 2020 · Autolus Therapeutics plc (Nasdaq AUTL) a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies today announced that management will host an investor conference call to discuss AUTO1 and AUTO3 data presented at the American Society of Hematology (ASH) Virtual Congress 2020 and will also participate in
Get PriceAutolus Therapeutics to host Investor Conference Calls
May 26 2020 · 1 June 2020Dr. Christian Itin chairman and chief executive officer along with the AUTO3 clinical team will host an investor call and webcast at 8.30 am EDT 1.30 pm BST to discuss presentations related to its AUTO3 program the company s CAR T cell therapy being investigated in the Alexander study a Phase 1/2 study in relapsed/refractory diffuse large B cell lymphoma (DLBCL)
Get PriceSyncona Ltd. (via Public) / Autolus Therapeutics to host
Autolus Therapeutics plc (Nasdaq AUTL) a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies today announced that management will host an investor conference call to discuss AUTO3 data presented at the European Society for Medical Oncology (ESMO) Virtual Congress 2020 and to participate in Banking conferences through September
Get PriceAutolus AutolusArix Bioscience
Apr 01 2021 · Autolus Therapeutics to host Investor Conference Call to discuss AUTO3 data presented at ESMO and to participate in Banking conferences through September. Portfolio Company. Autolus Therapeutics to host Investor Conference Calls through June. Portfolio Company. 22nd May 2020. Autolus Notice of Annual General Meeting (AGM) on Thursday June
Get PriceAutolus Therapeutics to host Investor Conference Call to
Autolus Therapeutics plc (Nasdaq AUTL) a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies today announced that management will host an investor conference call to discuss AUTO3 data presented at the European Society for Medical Oncology (ESMO) Virtual Congress 2020 and to participate in Banking conferences through September
Get PriceAutolus Therapeutics to host Investor Conference Call to
Autolus Therapeutics to host Investor Conference Call to discuss AUTO3 data presented at ESMO and to participate in Banking conferences through September September 8 2020. LONDON Sept. 08 2020(GLOBE NEWSWIRE) Autolus Therapeutics plc (Nasdaq AUTL) a clinical-stage biopharmaceutical company developing
Get PriceAutolus Therapeutics to host Investor Conference Call to
Nov 17 2020 · Autolus Therapeutics plc (Nasdaq AUTL) a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies today announced that management will host an investor conference call to discuss AUTO1 and AUTO3 data presented at the American Society of Hematology (ASH) Virtual Congress 2020 and will also participate in the Jefferies Banking Conference
Get PriceAutolus Therapeutics to Report First Quarter 2020
After the conference call a replay will be available for one week. To access the replay please dial (855) for U.S. and Canada callers or (404) for international callers. Please
Get PriceAutolus Therapeutics Limited (spons. ADRs) hosts
Mar 03 2021 · The company Autolus Therapeutics Limited (spons. ADRs) is set to host investors and clients on a conference call on 3/4/2021 10 26 30 PM. The call comes after the company s earnings which are
Get PriceAutolus Therapeutics to Report Second Quarter 2020
LONDON July 30 2020 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq AUTL) a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies today
Get PriceAutolus Therapeutics to host Investor Conference Calls
May 26 2020 · --Autolus Therapeutics plc a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies today announced that management will host investor conference calls
Get PriceAutolus Therapeutics to Report First Quarter 2020
After the conference call a replay will be available for one week. To access the replay please dial (855) for U.S. and Canada callers or (404) for international callers. Please
Get PriceAutolus Therapeutics to host Investor Conference Calls
May 26 2020 · Autolus Therapeutics plc (Nasdaq AUTL) a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies today announced that management will host investor conference calls through June. 1 June 2020
Get PriceAutolus Therapeutics to host Investor Conference Call to
Nov 17 2020 · Autolus Therapeutics to host Investor Conference Call to discuss AUTO1 and AUTO3 data presented at ASH and to participate in the Jefferies Virtual London Healthcare Conference November 17 2020 at 7 00 AM EST
Get PriceAutolus Therapeutics reschedules its investor EHA
Jun 08 2020 · --Autolus Therapeutics plc a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies today announced that it has rescheduled its investor conference call
Get PriceAutolus Therapeutics to host Investor Conference Call to
LONDON Sept. 08 2020 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (NASDAQ AUTL) a clinical-stage biopharmaceutical company developing next-generation programmed T cell
Get PriceAutolus Therapeutics to host Investor Conference Calls
May 26 2020 · Autolus Therapeutics to host Investor Conference Calls through June. After the conference call a replay will be available for one week. will host an investor call
Get PriceAutolus Therapeutics to host Investor Conference Calls
May 26 2020 · LONDON May 26 2020 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq AUTL) a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies today announced that management will host investor conference calls through June 1 June 2020Dr. Christian Itin chairman and chief executive officer along with the AUTO3 clinical team will host an investor
Get PriceAutolus Therapeutics to host Investor Conference Calls
May 26 2020 · LONDON May 26 2020 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc () a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies today announced that management will host investor conference calls through June 1 June 2020Dr. Christian Itin chairman and chief executive officer along with the AUTO3 clinical team will host an investor call
Get PriceAutolus Therapeutics to host Investor Conference Call to
Nov 17 2020 · Autolus Therapeutics to host Investor Conference Call to discuss AUTO1 and AUTO3 data presented at ASH and to participate in the Jefferies Virtual London Healthcare
Get Price
